Study on the clinical efficacy of Shi-Dan-Ke-Li in the treatment of chronic atrophic gastritis
- Conditions
- chronic atrophic gastritis
- Registration Number
- ITMCTR2024000145
- Lead Sponsor
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1) Meet the western medical diagnostic criteria for CAG (OLGA/OLGIM stage II and above).
2) Conforms to the Chinese medicine diagnosis of CAG of the weak spleen and stomach type (spleen and stomach cold deficiency syndrome).
3) Hp negative (at least one of C13 or C14 respiratory test is required)
4) Age 18-70 (including 18 and 70 years old), gender is not limited.
5) Voluntarily participate in this clinical trial, give informed consent and sign the informed consent form.
1 Pregnant and lactating women
2 Endoscopy suggests gastric cancer and patients with pathologically confirmed gastric cancer, high-grade intraepithelial neoplasia, and severe heterogeneous hyperplasia.
3 Endoscopy suggests peptic ulcer patients.
4 Patients with poor adherence to medical advice or allergy to the drug.
5 Patients who cannot tolerate endoscopy
6 Patients with serious mental disorders who are unable to co-operate.
7 Patients with abnormalities in liver and kidney function and coagulation.
8Patients participating in another clinical study at the same time.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pathological observation of stomach tissue;
- Secondary Outcome Measures
Name Time Method PGII;G17;PGI;